Disposable Specimen Container Market Report 2026

The disposable specimen container market size has grown strongly in recent years. It will grow from $2.66 billion in 2025 to $2.89 billion in 2026 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to rising demand for diagnostic testing, growing healthcare infrastructure, increasing awareness about infection control, rising prevalence of chronic and infectious diseases, and growing adoption of point-of-care testing.

The disposable specimen container market size is expected to see strong growth in the next few years. It will grow to $3.97 billion in 2030 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to increasing use of home healthcare testing, growing adoption of molecular diagnostics, rising government and private investments in laboratories, expanding clinical trial activities, and increasing demand for sterile and leak-proof containers. Major trends in the forecast period include advancement in container design and materials, technology integration for improved safety and efficiency, innovation in bio-based and recyclable materials, research and development of specialized containers for molecular diagnostics, and integration of automation and robotics in specimen processing.

The growing demand for hygienic medical sample handling is expected to drive the growth of the disposable specimen container market in the coming years. Hygienic medical sample handling involves the use of sterile, single-use devices to safely collect, store, and transport biological specimens without contamination, which is critical for accurate diagnostics and infection prevention in healthcare environments. This rising demand is linked to increasing volumes of diagnostic testing and a stronger emphasis on patient safety, prompting healthcare providers to implement more stringent infection-control measures. Disposable specimen containers support hygienic sample handling by preserving specimen integrity, preventing cross-contamination, and ensuring dependable laboratory analysis across healthcare settings. For example, in August 2024, according to NHS England, a UK-based government health authority, the number of diagnostic tests conducted rose from 2,254,600 in June 2023 to 2,328,300 in June 2024, reflecting a year-over-year increase of 3.3%. As a result, the heightened focus on hygienic medical sample handling is contributing to the expansion of the disposable specimen container market.

The rising prevalence of chronic diseases is also expected to propel the growth of the disposable specimen container market going forward. Chronic diseases are long-term health conditions that typically progress gradually, such as diabetes, heart disease, and arthritis, and often require continuous medical monitoring and management to control symptoms and reduce complications. The incidence of chronic diseases is increasing largely due to unhealthy lifestyle factors, including poor diet, physical inactivity, and smoking, which elevate the risk of conditions such as diabetes, cardiovascular disease, and obesity. Disposable specimen containers play a key role in chronic disease diagnosis by enabling safe, hygienic, and contamination-free collection of biological samples for precise laboratory testing. They enhance diagnostic accuracy and patient care by supporting regular monitoring and early identification of disease progression. For instance, in June 2024, according to the National Health Service, a UK-based government department, 3,615,330 individuals registered with a general practitioner were diagnosed with non-diabetic hyperglycemia or pre-diabetes in 2023, representing an 18% increase from 3,065,825 cases in 2022. Consequently, the growing burden of chronic diseases is driving the expansion of the disposable specimen container market.

Major companies operating in the disposable specimen container market are emphasizing the development of enhanced specimen containers, including multi-click seal vials and containers, that clearly indicate proper sealing to ensure secure sample collection and transportation. Multi-click seal vials and containers are engineered to preserve sample integrity throughout handling, storage, and transport while reducing the risk of contamination or leakage. For example, in April 2025, Thermo Fisher Scientific, a US-based life sciences company, introduced Samco Clicktainer Vials and Specimen Containers. These products incorporate an audible, visual, and tactile multi-click seal closure to verify correct sealing, offer compatibility with both sterile and non-sterile formats to suit varied clinical workflows, and provide a wide selection of cap color options to aid sample identification. This introduction marks a significant technological advancement by combining ease of use, safety, and versatility, delivering laboratories a dependable solution for secure specimen handling and precise diagnostic testing.

Major companies operating in the disposable specimen container market are Cardinal Health Inc., Thermo Fisher Scientific Inc., Becton Dickinson and Company, SARSTEDT AG & Co. KG, Greiner Bio-One International GmbH, Kabe Labortechnik GmbH, Jiangsu Kangjin Medical Instruments Co. Ltd., Polymed Medical Devices, Citotest Scientific Co. Ltd., HiMedia Laboratories Pvt. Ltd., CML Biotech Pvt. Ltd., Deltalab S.L., Medline Industries LP, Simport Scientific Inc., Abdos Labtech Pvt. Ltd., Globe Scientific Inc., Heathrow Scientific LLC, VITLAB GmbH, FL Medical S.r.l., Aptaca S.p.A., Kartell S.p.A.

North America was the largest region in the disposable specimen container market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the disposable specimen container market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the disposable specimen container market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Tariffs have impacted the disposable specimen container market by increasing the cost of imported raw materials such as polypropylene and polyethylene, thereby affecting manufacturing expenses and pricing strategies. regions like north america and europe, which rely on imports for specialized containers, are most affected, while asia-pacific manufacturers experience both challenges and opportunities in export competitiveness. some positive effects include encouraging local production and innovation in cost-effective container solutions, ultimately supporting market resilience and diversification.

Disposable specimen containers are single-use medical devices intended for the secure collection, storage, and transportation of biological samples such as urine, stool, sputum, blood, and other bodily fluids for diagnostic testing and laboratory analysis. These containers are generally made from plastic or glass and are produced in a range of sizes and designs, incorporating features like leak-proof caps, tamper-evident seals, measurement graduations, and sterile interiors to avoid contamination and maintain sample integrity.

The primary product types of disposable specimen containers include urine containers, stool containers, sputum containers, blood containers, and multi-purpose containers. Urine specimen containers are single-use, leak-resistant containers designed for safe collection, storage, and transport of urine samples while preserving sample integrity and minimizing contamination risk. Sterility options include sterile and non-sterile containers. Key raw materials include polypropylene, high-density polyethylene, polyvinyl chloride, and others. Distribution channels include direct sales, medical device distributors, and online platforms, with end users such as hospitals, diagnostic laboratories, clinics, research institutes, and home-healthcare settings.

The disposable specimen container market consists of sales of rine specimen containers, stool specimen containers, blood specimen containers, saliva and oral fluid containers, sputum specimen containers, specialized specimen containers for tissue or microbiology samples, and accessories and kits including lids, caps, preservatives, and transport packaging. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.